Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. [electronic resource]
Producer: 20160104Description: 3699-705 p. digitalISSN:- 1538-7445
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Carcinoma, Pancreatic Ductal -- drug therapy
- Cell Division -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Deoxycytidine -- administration & dosage
- Disease Progression
- Drug Synergism
- Epithelial-Mesenchymal Transition -- drug effects
- Female
- Gene Knockdown Techniques
- Humans
- Intercellular Signaling Peptides and Proteins -- physiology
- Mice
- Mice, Inbred C57BL
- Mice, Inbred NOD
- Mice, SCID
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Neoplasm Proteins -- antagonists & inhibitors
- Pancreatic Neoplasms -- drug therapy
- Proto-Oncogene Proteins -- antagonists & inhibitors
- RNA, Small Interfering -- pharmacology
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Specific Pathogen-Free Organisms
- Warfarin -- administration & dosage
- Xenograft Model Antitumor Assays
- Gemcitabine
- Axl Receptor Tyrosine Kinase
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.